TEST BANK FOR PSYCHOPHARMACOLOGY
DRUGS THE BRAIN AND BEHAVIOR 4TH EDITION
BY MEYER NURSING, VERIFIED CHAPTERS 1 - 20
Page 1 of 247
bg bg bg
,Chapter 1. Principles of Pharmacology
Chapter 2. Structure and Function of the Nervous System
Chapter 3. Chemical Signaling by Neurotransmitters and Hormones
Chapter 4. Methods of Research in Psychopharmacology
Chapter 5. Catecholamines
Chapter 6. Serotonin
Chapter 7. Acetylcholine
Chapter 8. Glutamate and GABA
Chapter 9. Drug Abuse and Addiction
Chapter 10. Alcohol
Chapter 11. The Opioids
Chapter 12. Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs
Chapter 13. Nicotine and Caffeine
Chapter 14. Marijuana and the Cannabinoids
Chapter 15. Hallucinogens, PCP, and Ketamine
Chapter 16. Inhalants, GHB, and Anabolic-Androgenic Steroids
Chapter 17. Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These
Disorders
Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers
Chapter 19. Schizophrenia: Antipsychotic Drugs
Chapter 20. Neurodegenerative Diseases
Page 2 of 247
bg bg bg
, Chapter 1: Principles of Pharmacology
Multiple Choice bg
1. bg
refer(s) to specific molecular changes that occur when a drug binds to a particular targe
bg bg bg bg bg bg bg bg bg bg bg bg bg bg
t site or receptor, while
bg bg bg bg
are the resulting widespread alterationsin function.
bg bg bg bg bg bg
a. Drug action; therapeutic effects bg bg bg
b. Side effects; drug effects bg bg bg
c. Therapeutic effects; side effects bg bg bg
d. Drug action; drug effects bg bg bg
ANSWER: d bg
Textbook Reference: Pharmacology: The Science of Drug Action
bg bg bg bg bg bg bg
2. After drug administration has occurred, the amount of drug in the blood that is free tobin
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
d at specific target sites is referred to as
bg bg bg bg bg bg bg bg
a. the therapeutic dose. bg bg
b. first-pass effects. bg
c. bioavailability.
d. ED50.
ANSWER: c bg
Textbook Reference: Pharmacokinetic Factors Determining Drug Action
bg bg bg bg bg bg
3. The specific molecular changes that occur when a drug binds to a particular target siteor
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
receptor are referred to as bg bg bg bg
a. drug effects. bg
b. drug action. bg
c. side effects. bg
Page 3 of 247
bg bg bg
, d. placebo effects.
bg
ANSWER: b bg
Textbook Reference: Pharmacology: The Science of Drug Action
bg bg bg bg bg bg bg
4. Which of the following is not a possible explanation for placebo effects?
bg bg bg bg bg bg bg bg bg bg bg
a. Pavlovian conditioning bg
b. Genetic variation
bg
c. Drug competition
bg
d. Expectation of outcome bg bg
ANSWER: c bg
Textbook Reference: Pharmacology: The Science of Drug Action
bg bg bg bg bg bg bg
Page 4 of 247
bg bg bg
DRUGS THE BRAIN AND BEHAVIOR 4TH EDITION
BY MEYER NURSING, VERIFIED CHAPTERS 1 - 20
Page 1 of 247
bg bg bg
,Chapter 1. Principles of Pharmacology
Chapter 2. Structure and Function of the Nervous System
Chapter 3. Chemical Signaling by Neurotransmitters and Hormones
Chapter 4. Methods of Research in Psychopharmacology
Chapter 5. Catecholamines
Chapter 6. Serotonin
Chapter 7. Acetylcholine
Chapter 8. Glutamate and GABA
Chapter 9. Drug Abuse and Addiction
Chapter 10. Alcohol
Chapter 11. The Opioids
Chapter 12. Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs
Chapter 13. Nicotine and Caffeine
Chapter 14. Marijuana and the Cannabinoids
Chapter 15. Hallucinogens, PCP, and Ketamine
Chapter 16. Inhalants, GHB, and Anabolic-Androgenic Steroids
Chapter 17. Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These
Disorders
Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers
Chapter 19. Schizophrenia: Antipsychotic Drugs
Chapter 20. Neurodegenerative Diseases
Page 2 of 247
bg bg bg
, Chapter 1: Principles of Pharmacology
Multiple Choice bg
1. bg
refer(s) to specific molecular changes that occur when a drug binds to a particular targe
bg bg bg bg bg bg bg bg bg bg bg bg bg bg
t site or receptor, while
bg bg bg bg
are the resulting widespread alterationsin function.
bg bg bg bg bg bg
a. Drug action; therapeutic effects bg bg bg
b. Side effects; drug effects bg bg bg
c. Therapeutic effects; side effects bg bg bg
d. Drug action; drug effects bg bg bg
ANSWER: d bg
Textbook Reference: Pharmacology: The Science of Drug Action
bg bg bg bg bg bg bg
2. After drug administration has occurred, the amount of drug in the blood that is free tobin
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
d at specific target sites is referred to as
bg bg bg bg bg bg bg bg
a. the therapeutic dose. bg bg
b. first-pass effects. bg
c. bioavailability.
d. ED50.
ANSWER: c bg
Textbook Reference: Pharmacokinetic Factors Determining Drug Action
bg bg bg bg bg bg
3. The specific molecular changes that occur when a drug binds to a particular target siteor
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg
receptor are referred to as bg bg bg bg
a. drug effects. bg
b. drug action. bg
c. side effects. bg
Page 3 of 247
bg bg bg
, d. placebo effects.
bg
ANSWER: b bg
Textbook Reference: Pharmacology: The Science of Drug Action
bg bg bg bg bg bg bg
4. Which of the following is not a possible explanation for placebo effects?
bg bg bg bg bg bg bg bg bg bg bg
a. Pavlovian conditioning bg
b. Genetic variation
bg
c. Drug competition
bg
d. Expectation of outcome bg bg
ANSWER: c bg
Textbook Reference: Pharmacology: The Science of Drug Action
bg bg bg bg bg bg bg
Page 4 of 247
bg bg bg